Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (58)
  • 2024 (43)
  • 2023 (80)
  • 2022 (102)
  • 2021 (81)
  • 2020 (16)
  • 2019 (22)
  • 2018 (7)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4016)
  • Synthetic drugs (1067)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (605)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (458)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (243)
  • Task Forces/Task Force Officers (231)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (111)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (7)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (364)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)

Drug Name

  • Oxycodone (78)
  • Fentanyl (70)
  • Opioids (64)
  • Synthetic Opioids (29)
  • Methamphetamine (21)
  • Hydromorphone (18)
  • Benzodiazepines (14)
  • Amphetamines (10)
  • Morphine (10)
  • Cocaine (8)
  • Heroin (6)
  • Methadone (6)
  • Marijuana (Cannabis) (4)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (52)
  • St. Louis (42)
  • New York (36)
  • Sede (28)
  • New England (25)
  • Seattle (24)
  • Atlanta (19)
  • El Paso (19)
  • New Jersey (19)
  • Miami (18)
  • Omaha (18)
  • Chicago (17)
  • Dallas (16)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • New Orleans (10)
  • Los Angeles (9)
  • San Diego (9)
  • Rocky Mountain (7)
  • Phoenix (6)
  • Detroit (3)
  • Philadelphia (2)
Clear All Results
PRESS RELEASE

Osteopathic Physician Sentenced for Illegally Prescribing Drug

Septiembre 07, 2022
ST. LOUIS – U.S. District Judge Ronnie L. White on Wednesday sentenced an osteopathic physician from Collinsville, Illinois, to a year in prison for illegally prescribing an anti-anxiety drug. Matthew Steven Miller, 43, wrote prescriptions for the anti-anxiety drug Xanax for six people who were not his patients between 2016...
Septiembre 07, 2022
PRESS RELEASE

DEA Reaches Agriculture Community at Farm Progress Show with Important Message About Fentanyl

Agosto 30, 2022
OMAHA, Neb. – Representatives with the Drug Enforcement Administration (DEA) Omaha Division are engaging with visitors at the Farm Progress Show beginning today in Boone, Iowa, by hosting a booth in the Varied Industries Tent and raising awareness and education regarding drug trends in the Midwest. “We know from experience...
Agosto 30, 2022
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

Agosto 19, 2022
NEW YORK CITY – On Sunday, August 21, the Drug Enforcement Administration will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several...
Agosto 19, 2022
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

Agosto 19, 2022
NEWARK, N.J. – On Sunday, August 21, the Drug Enforcement Administration will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several organizations...
Agosto 19, 2022
PRESS RELEASE

DEA Recognizes National Fentanyl Prevention and Awareness Day

Agosto 19, 2022
EL PASO – On Sunday, August 21, the Drug Enforcement Administration will recognize National Fentanyl Prevention and Awareness Day by joining the many voices dedicated to educating the public on the serious dangers of fentanyl poisoning from fake pills and other illicit drugs. DEA supports the efforts of several organizations...
Agosto 19, 2022
PRESS RELEASE

New Jersey Pharmacy Admits Illegal Distribution of Prescription Opioids and Kickback Scheme

Agosto 03, 2022
NEWARK, N.J. – Susan A. Gibson, Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division, Scott J. Lampert, Special Agent in Charge of the U.S. Department of Health and Human Services, Office of Inspector General, Office of Investigations-New Jersey Field Office, Patrick J. Hegarty, Defense Criminal Investigative...
Agosto 03, 2022
PRESS RELEASE

DEA Reminds Families to Discuss the Dangers of Drugs Before Students Return to School

Agosto 01, 2022
OMAHA, Neb. – As students across Nebraska prepare for a return to school, the Drug Enforcement Administration (DEA) Omaha Division encourages families to make time for conversations about the dangers of drug use and consequences of experimentation. Methamphetamine and fake pill seizures remain high in Nebraska and the DEA wants...
Agosto 01, 2022
PRESS RELEASE

Justice Department Obtains Temporary Restraining Order to Prevent Tampa-Area Physician from Writing Opioid Prescriptions

Julio 29, 2022
WASHINGTON – A federal court issued a temporary restraining order prohibiting a Tampa-area physician from prescribing opioids and other controlled substances, the Department of Justice announced today. In a complaint filed on July 18, and unsealed yesterday, the United States alleges that Dr. Neelam Taneja Uppal unlawfully wrote opioid prescriptions...
Julio 29, 2022
PRESS RELEASE

Federal Court Orders Clinic to Close, Physician and Clinic Owners to Pay $600,000 for Alleged Unlawful Opioid Distribution

Julio 27, 2022
WASHINGTON – A federal court ordered a Tampa-area pain management clinic to close and directed the clinic’s owners and its former physician to collectively pay $600,000 in civil penalties pursuant to agreed resolutions in a case alleging violations of the Controlled Substances Act (CSA), the Justice Department announced today. In...
Julio 27, 2022
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

Julio 20, 2022
MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
Julio 20, 2022
Showing 211 - 220 of 413 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 18
  • Página 19
  • Página 20
  • Página 21
  • Current page 22
  • Página 23
  • Página 24
  • Página 25
  • Página 26
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster